Search Within

Computational Oncology Service

  1. "Early Drug Development Service"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (22)
  3. Research Letter (1)
Groups
  1. Department of Medicine (51)
  2. Early Drug Development Service (51)
  3. Epidemiology and Biostatistics (51)
  4. Solid Tumor Oncology Division (51)
  5. GSK Faculty (50)
  6. Human Oncology and Pathogenesis Program (50)

More Groups

People
  1. David Hyman (48)
  2. David Solit (38)
  3. Michael Berger (38)
  4. Nikolaus Schultz (36)
  5. Ahmet Zehir (32)
  6. Marc Ladanyi (26)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (6)
  5. 2019 (11)
  6. 2018 (12)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer Discovery (7)
  3. Cancer Research (7)
  4. JCO Precision Oncology (5)
  5. Annals of Oncology (4)
  6. Blood (3)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. American Society of Clinical Oncology (15)
  3. Nature Publishing Group (6)
  4. Oxford University Press (4)
  5. American Society of Hematology (3)
  6. Cell Press (2)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention
    Journal Article

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Capanu, M.; Kemeny, N. E.; O'Reilly, E. M.; El-Dika, I.; Jarnagin, W. R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Genome doubling shapes the evolution and prognosis of advanced cancers
    Journal Article

    Bielski, C. M.; Zehir, A.; Penson, A. V.; Donoghue, M. T. A.; Chatila, W.; Armenia, J.; Chang, M. T.; Schram, A. M.; Jonsson, P.; Bandlamudi, C.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save